Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Filed with BSE · · 2 pages · English
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Aug 09 2026
- Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026
- Sudarshan Pharma Industries Ltd Press Release Jul 14 2026
- Sudarshan Pharma Industries Ltd Press Release Jul 07 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Investor Presentation
- FCCB Committee Meeting On Wednesday, 19-August-2026
- Sudarshan Pharma Industries Ltd Press Release Aug 14 2026
- Sudarshan Pharma Industries Ltd Press Release Aug 17 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries